Question 1

What is Yves Decadt?

Accepted Answer

Yves Decadt is a Person.

Question 2

How often does Yves Decadt appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Yves Decadt first tracked by Ergen?

Accepted Answer

First tracked on Jun 10, 2026.

Question 4

When was Yves Decadt last mentioned in news?

Accepted Answer

Last active on Jun 10, 2026.

Question 5

What is Yves Decadt's current news sentiment?

Accepted Answer

Aggregate sentiment score: 50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Yves Decadt in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Yves Decadt?

Accepted Answer

Poxel Appoints Yves Decadt CEO (Jun 10, 2026, 6 articles).

Question 8

How did the "Poxel Appoints Yves Decadt CEO" event impact Yves Decadt?

Accepted Answer

Yves Decadt>>> was appointed CEO of Poxel>>> to lead the operational implementation of its Continuation Plan, focusing on commercializing Imeglimin and developing PXL065. He brings over 25 years of international pharmaceutical experience, including significant time at Johnson & Johnson>>>.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.